LAVA Therapeutics N.V. (“LAVA”) (NASDAQ: LVTX) today announced a reminder to LAVA shareholders related to the proposed transaction with XOMA Royalty Corporation (“XOMA”) (NASDAQ: XOMA). On August 4, ...
Secured $9.7bn AI Cloud Contract with Microsoft Targeting $3.4bn AI Cloud ARR by End of 2026, Expansion to 140k GPUs1NEW YORK, Nov. 06, 2025 ...
Based on information as of November 6, 2025, the Company is issuing the following financial guidance. Revenue is expected to be in the range of $59.0 – $60.0 million. Adjusted Operating Income is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback